Development of patient-specific human organoids models for heart, liver, and kidney tissues ...

Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patientswith and without liver metastases Study will be ...

The tumor microbiota—which includes bacteria, fungi, viruses, and other microorganisms present in tumor tissue—is now ...

Targeting organ‑specific gene “switches” can reverse key markers of liver aging in mice, suggesting aging might be slowed one ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

A new 2026 study reveals how chronic stress depletes NAD⁺, impairing immunity and accelerating liver cancer—while linking the ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

Engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure. More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a ...

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion’s strategic shift to advancing clinically proven ...

Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup. More than 100 million people in the United States suffer from metabolic ...